Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Epogen

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epogen was produced by Amgen.

Pfizer gets FDA panel recommendation for biosimilar EPO

Pfizer gets FDA panel recommendation for biosimilar EPO

Pfizer gets FDA panel recommendation for biosimilar EPO. Product could be the first direct competitor to Epogen and Procrit in the US. ... Amgen reported Epogen sales of $1.3bn last year – all from the US market – while Procrit earned $1.1bn for J&J,

Novartis gets FDA panel backing for biosimilar Enbrel

Novartis gets FDA panel backing for biosimilar Enbrel The company has several other biosimilars in clinical development, including copycat versions of Humira, Roche's MabThera/Rituxan (rituximab), Amgen's Epogen (epoetin alfa) and Neulasta (pegfilgrastim) and Johnson &Johnson's

Amgen biosimilar matches AbbVie's Humira in psoriasis trial

Amgen biosimilar matches AbbVie's Humira in psoriasis trial to its own drugs such as Neupogen (filgrastim) and Epogen (epoetin alfa) in Europe.

Omontys terminal as Takeda switches off support

Omontys terminal as Takeda switches off support by Epogen (epoetin alfa) and long-acting follow-up Aranesp (darbepoetin alfa).

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics